Market research
SYK.F Stryker Corporation
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 108B
- P/E ratio
- 34.21
- Analyst target
- 287.72
- Dividend yield
- 1.2%
- Beta
- 0.77
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US8636671013
- Market cap
- 108B
- P/E ratio
- 34.21
- Analyst target
- 287.72
- Dividend yield
- 1.2%
- Beta
- 0.77
About
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SYK.F discussion.
5 years, 5 months ago
Stryker Corporation is currently in a long term uptrend where the price is trading 10.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.4.
Stryker Corporation's total revenue rose by 3.2% to $4B since the same quarter in the previous year.
Its net income has dropped by 21.7% to $568M since the same quarter in the previous year.
Finally, its free cash flow grew by 100.0% to $1B since the same quarter in the previous year.
Based on the above factors, Stryker Corporation gets an overall score of 4/5.